Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosaku Nitta

Showing results (351-360 of 534) with videos related to

Pageof 54
Sort By:
Clinical and Experimental Nephrology|June 29, 2018
Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC studyKosaku Nitta, Satoshi Iimuro, Enyu Imai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2022
Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new associationJunichi Hoshino, Masanori Abe, Takayuki Hamano, et al.
Contributions to Nephrology|April 17, 2019
Carnitine Profile by Tandem Mass Spectrometry and Dialysis PatientsDaigo Kamei, Yuiko Kamei, Nobue Tanaka, et al.
American Journal of Physiology. Renal Physiology|February 17, 2012
Reduced Klotho expression level in kidney aggravates renal interstitial fibrosisHidekazu Sugiura, Takumi Yoshida, Shunji Shiohira, et al.
Plos One|May 30, 2020
Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in JapanEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 20, 2004
Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scanKosaku Nitta, Takashi Akiba, Koichi Suzuki, et al.
Plos One|March 9, 2018
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat modelHidekazu Sugiura, Ai Matsushita, Mayuko Futaya, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
Clinical and Experimental Nephrology|July 21, 2011
Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patientsShunji Shiohira, Takumi Yoshida, Hidekazu Sugiura, et al.
Scientific Reports|March 9, 2022
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER StudyHiroshi Kataoka, Toshio Mochizuki, Mamiko Ohara, et al.
Pageof 54

Showing results (351-360 of 534) with videos related to

Sort By:
Pageof 54
Clinical and Experimental Nephrology|June 29, 2018
Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC studyKosaku Nitta, Satoshi Iimuro, Enyu Imai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2022
Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new associationJunichi Hoshino, Masanori Abe, Takayuki Hamano, et al.
Contributions to Nephrology|April 17, 2019
Carnitine Profile by Tandem Mass Spectrometry and Dialysis PatientsDaigo Kamei, Yuiko Kamei, Nobue Tanaka, et al.
American Journal of Physiology. Renal Physiology|February 17, 2012
Reduced Klotho expression level in kidney aggravates renal interstitial fibrosisHidekazu Sugiura, Takumi Yoshida, Shunji Shiohira, et al.
Plos One|May 30, 2020
Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in JapanEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 20, 2004
Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scanKosaku Nitta, Takashi Akiba, Koichi Suzuki, et al.
Plos One|March 9, 2018
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat modelHidekazu Sugiura, Ai Matsushita, Mayuko Futaya, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
Clinical and Experimental Nephrology|July 21, 2011
Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patientsShunji Shiohira, Takumi Yoshida, Hidekazu Sugiura, et al.
Scientific Reports|March 9, 2022
Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER StudyHiroshi Kataoka, Toshio Mochizuki, Mamiko Ohara, et al.
Pageof 54